Imaging immunomodulatory treatment responses in a multiple sclerosis mouse model using hyperpolarized 13C metabolic MRI

Abstract Background In recent years, the ability of conventional magnetic resonance imaging (MRI), including T1 contrast-enhanced (CE) MRI, to monitor high-efficacy therapies and predict long-term disability in multiple sclerosis (MS) has been challenged. Therefore, non-invasive methods to improve M...

Full description

Bibliographic Details
Main Authors: Caroline Guglielmetti, Christian Cordano, Chloé Najac, Ari J. Green, Myriam M. Chaumeil
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-023-00300-1